Serotiny
OverviewSuggest Edit
Serotiny is a company that is engaged in the discovery of proteins for cell therapies. It focuses on such proteins as CARs (chimeric antigen receptors) for the treatment of cancers and genetic disorders.
| Type | Private | |
| Founded | 2014 | |
| Website | serotiny.bio |
Latest Updates
| Employees (est.) (Feb 2021) | 11 | (+10%) |
| Cybersecurity rating | B | More |
Serotiny Financials and Metrics
Summary Metrics
Founding Date | 2014 |
Serotiny total Funding | $3 m |
Serotiny latest funding size | $3 m |
Time since last funding | 3 years ago |
Serotiny investors | NanoDimension, 8VC |
Serotiny's latest funding round in July 2018 was reported to be $3 m. In total, Serotiny has raised $3 m
Serotiny Cybersecurity Score
Serotiny Online and Social Media Presence
58 Twitter followers
Serotiny has 58 Twitter Followers. The number of followers has increased 0.7% month over month and increased 0.7% quarter over quarter
Serotiny's Trends
Serotiny Frequently Asked Questions
When was Serotiny founded?
Serotiny was founded in 2014.
How many employees does Serotiny have?
Serotiny has 11 employees.
Who are Serotiny competitors?
Competitors of Serotiny include Rznomics, Paragon Gene Therapy and Senhwa Biosciences.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies